Market revenue in 2024 | USD 7,897.5 million |
Market revenue in 2030 | USD 11,130.0 million |
Growth rate | 5.9% (CAGR from 2024 to 2030) |
Largest segment | Defibrillators |
Fastest growing segment | Defibrillators |
Historical data covered | 2018 - 2023 |
Base year for estimation | 2024 |
Forecast period covered | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Pacemakers, Defibrillators, Cardiac Resynchronization Therapy (CRT) |
Key market players worldwide | Stryker Corp, BIOTRONIK, SCHILLER, Medtronic PLC, Abbott Laboratories, Koninklijke Philips NV, ZOLL Medical Corporation, Boston Scientific Corp, LivaNova PLC, Progetti Medical |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cardiac rhythm management devices market will help companies and investors design strategic landscapes.
Defibrillators was the largest segment with a revenue share of 43.29% in 2024. Horizon Databook has segmented the North America cardiac rhythm management devices market based on pacemakers, defibrillators, cardiac resynchronization therapy (crt) covering the revenue growth of each sub-segment from 2018 to 2030.
North America dominated the global cardiac rhythm management devices (CRMDs) market in 2023. The high prevalence of cardiovascular diseases, including arrhythmias, heart failure, and cardiac arrest, drives the demand for CRMDs in North America. As the population ages & risk factors such as obesity and diabetes increase, the incidence of these conditions is expected to rise, further fueling market growth.
Developed markets such as Canada and the U.S. are majorly focused on improving public access to defibrillators. The Automated External Defibrillators (AEDs) mostly dominate this market, and several companies in this market are making efforts to improve access to defibrillators.
These initiatives are expected to drive the CRMDs market in this region. Implementation of supportive healthcare regulations has resulted in enhanced accessibility of public places and government facilities for patients with heart conditions.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America cardiac rhythm management devices market, including forecasts for subscribers. This continent databook contains high-level insights into North America cardiac rhythm management devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account